April 22, 2021 Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease read more
March 26, 2021 Quanterix’ Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples read more
March 17, 2021 Quanterix’ Simoa Technology Accelerates Critical Plasma Biomarker Research Presented at the 15th International Conference on Parkinson’s & Alzheimer’s Disease (AD/PDTM 2021) read more
March 2, 2021 Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020 read more
February 23, 2021 Quanterix Corporation To Release Fourth Quarter And Full Year 2020 Financial Results On March 2, 2021 read more
February 8, 2021 Quanterix Announces Closing of Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares read more